Related Experiment Videos
Coronary veins: an alternate route to ischemic myocardium
1Cedars-Sinai Medical Center, Los Angeles, Calif. 90048.
Insights
Synchronized coronary venous retroperfusion offers a novel approach to mitigate myocardial ischemia during procedures like angioplasty. This technique shunts blood to the heart, potentially improving outcomes for patients with acute myocardial infarction and unstable angina.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
Background:
- Acute myocardial ischemia is a critical concern in myocardial infarction and unstable angina.
- Rapid restoration of blood flow is essential for successful reperfusion therapy.
- Ischemia, even brief, can lead to reversible myocardial dysfunction.
Purpose of the Study:
- To evaluate synchronized coronary venous retroperfusion as a myocardial support technique.
- To assess the efficacy of retroperfusion in ameliorating ischemia during angioplasty.
- To explore retroperfusion's potential in managing medically refractory unstable angina.
Main Methods:
- Utilizes synchronized coronary venous retroperfusion, shunting autologous arterial blood from the femoral artery to the ischemic myocardium via the coronary sinus.
- Clinical studies have investigated its application during angioplasty procedures.
- Preliminary reports examine its use in unstable angina.
Main Results:
- Retroperfusion has been shown to ameliorate and delay the onset of ischemia during angioplasty.
- The technique has proven beneficial during abrupt coronary artery closure post-angioplasty.
- Preliminary findings suggest efficacy in medically refractory unstable angina.
Conclusions:
- Synchronized coronary venous retroperfusion is a promising myocardial support strategy.
- Its retrograde approach offers an alternative route for delivering blood and cardioprotective agents to ischemic myocardium.
- This technique may improve outcomes in patients experiencing acute myocardial ischemia.
Abstract:
Acute myocardial ischemia is the primary cause of concern during myocardial infarction and unstable angina, and the cornerstone of modern therapy is rapid establishment of antegrade blood flow. The ultimate success of reperfusion depends on the duration and severity of ischemia before revascularization. Even brief ischemia occurring during angioplasty may cause reversible myocardial dysfunction. Several interventions are available to minimize the negative effects of acute myocardial ischemia. Synchronized coronary venous retroperfusion is a myocardial support technique in which autologous arterial blood is shunted from the femoral artery into the ischemic myocardium via the coronary sinus. Retroperfusion has been studied clinically during angioplasty and has been shown to ameliorate and delay the onset of ischemia. It has also been beneficial during abrupt closure of the coronary artery after angioplasty as a bridge to definitive therapy. Preliminary reports have indicated the efficacy of retroperfusion in medically refractory unstable angina. Because of its retrograde approach, this technique may serve as an alternate route to an otherwise inaccessible, ischemic myocardium for delivery of blood and other cardioprotective agents.